Monte Rosa Therapeutics Inc (NASDAQ:GLUE) Surging 25.44% In 6 Months – Here’s What To Expect
Monte Rosa Therapeutics Inc (NASDAQ:GLUE)’s traded shares stood at 99848.0 during the last session, with the company’s beta value hitting 1.45. At the close of